Abstract:Placenta Accreta Spectrum (PAS) is a life-threatening condition in which placental trophoblastic cells abnormally invade the uterus, often up to the uterine serosa and, in extreme cases, tissues beyond the uterine wall. Currently, there is no clinical assay for the non-invasive detection of PAS, and only ultrasound and MRI can be used for its diagnosis. Considering the subjectivity of visual assessment, the detection of PAS necessitates a high degree of expertise and, in some instances, can lead to its misdiagnosis. In clinical practice, up to 50% of pregnancies with PAS remain undiagnosed until delivery, and it is associated with increased risk of morbidity/mortality. Although many studies have evaluated the potential of fetal biomarkers circulating in maternal blood, very few studies have evaluated the potential of circulating placental extracellular vesicles (EVs) and their miRNA contents for molecular detection of PAS. Thus, to purify placental EVs from maternal blood, we customized our robust ultra-sensitive immuno-purification assay, termed EV-CATCHER, with a monoclonal antibody targeting the membrane Placental Alkaline Phosphatase (PLAP) protein, which is unique to the placenta and present on the surface of placental EVs. Then, as a pilot evaluation, we compared the miRNA expression profiles of placental EVs purified from the maternal plasma of women diagnosed with placenta previa (controls, n = 16); placenta lying low in uterus but not invasive) to those of placental EVs purified from the plasma of women with placenta percreta (cases, n = 16), PAS with the highest level of invasiveness. Our analyses reveal that miRNA profiling of PLAP+ EVs purified from maternal plasma identified 40 differentially expressed miRNAs when comparing these two placental pathologies. Preliminary miRNA pathway enrichment and gene ontology analysis of the top 14 upregulated and top nine downregulated miRNAs in PLAP+ EVs, purified from the plasma of women diagnosed with placenta percreta versus those diagnosed with placenta previa, suggests a potential role in control of cellular invasion and motility that will require further investigation.

Study of syncytiotrophoblast microparticles' preparation method

Expression and Distribution of Calcium-Binding Protein S100P in Human Placenta During Pregnancy

A method to isolate syncytiotrophoblast-derived medium-large extracellular vesicle small RNA from maternal plasma

Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset severe pre-eclampsia.

Comparative Proteomic Analysis of Human Placenta Derived from Assisted Reproductive Technology

Isolation and identification of placental exosomes from maternal serum

Effects of syncytiotrophoblast microparticles on proliferation and apoptosis of human umbilical vein endothelial cells.

Proteome analysis of a plasma membrane-enriched fraction at the placental feto-maternal barrier

Isolation of pure primary term human cytotrophoblasts and their differentiation into syncytiotrophoblast-like cells as an ex vivo model of the human placenta

An optimized proteomics-based approach to estimate blood contamination and cellular heterogeneity of frozen placental tissue

Isolation and Characterization of Mesenchymal Stem Cells from Human Placenta

Polymer-based precipitation preserves biological activities of extracellular vesicles from an endometrial cell line

Culture in Vitro and Identification of Hofbauer Cells from Human Placenta

Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies

Biological, immunological and regenerative characteristics of placenta-derived mesenchymal stem cell isolated using a time-gradient attachment method

One-step Preparation of Boronic Acid-Rich Hydrothermal Spheres for N-glycopeptide Analysis from Preeclampsia Serum.

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Co-culture of human extravillous cytotrophoblasts and human umbilical artery smooth muscle cells in vitro

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Proteomic Analysis in Placental Trophoblasts of Pre-Eclampia Patients